Elisabeth Bjork - Jun 14, 2021 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Sara Turken, as attorney-in-fact
Stock symbol
RCKT
Transactions as of
Jun 14, 2021
Transactions value $
$49,985
Form type
4
Date filed
6/16/2021, 07:55 PM
Next filing
Jun 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +12.2K $0.00 12.2K Jun 14, 2021 Common Stock 12.2K $47.25 Direct F1
transaction RCKT Stock Option (Right to Buy) Award $50K +1.7K $29.42 1.7K Jun 14, 2021 Common Stock 1.7K $47.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 12,236 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022.
F2 This option represents a right to purchase a total of 1,699 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022. This option was issued to the Reporting Person in lieu of director retainer fees of $50,000.